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The Spontaneously Diabetic Torii (SDT) rat, a newly
established animal model for diabetes mellitus, presents
nonobese type 2 diabetes with ocular complications. In the
present study, oral glucose tolerance tests and biochemical
and histopathological examinations were performed in fe-
maleSDTratsat16and/or25weeksofage,beforetheonset
ofdiabetes.At25weeksofage,glucosetolerancewassignif-
icantlyimpaired,andplasmaimmunoreactiveinsulinlevels
at 120 min after glucose loading were signiﬁcantly higher
(P < 0.05). Body weight and fasting levels of plasma triglyc-
eridesandnonesteriﬁedfattyacidsweresigniﬁcantlyhigher
than those in control animals. Histopathologically, inﬂam-
matory cell inﬁltration and ﬁbrosis were observed in and
around the pancreatic islets. These results strongly suggest
that female SDT rats are useful as a model to investigate
impairment of glucose tolerance and hyperlipidemia prior
to the onset of diabetes.
Keywords Animal model; Diabetes; Female SDT Rat; Glucose In-
tolerance;Hyperlipidemia;ImpairedGlucoseTolerance;
Pancreatic Fibrosis
INTRODUCTION
The Spontaneously Diabetic Torii (SDT) rat, a new animal
model of nonobese type 2 diabetes, is characterized by the oc-
ular complications (cataracts and retinopathy) [1]. This strain
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has been used to investigate whether pancreas transplantation
(PTx) performed before the “point of no return” prevent/cure
diabetic ocular complications [2]. We previously have reported
sexualdifferencesintheincidenceofdiabetesinthisstrain;glu-
cosuria appeared at 20 weeks of age in males but at 45 weeks
of age in females. Although the cumulative incidence of dia-
betes was 100% at 40 weeks of age in males, it was 33.3% by
65 weeks in females [1]. This higher incidence of diabetes in
males also has been reported in several models of spontaneous
type 2 diabetes, such as NSY mice[3], TSOD mice [4], Wistar
fattyrats[5],Zuckerdiabeticfattyrats[6],andOLETFrats[7].
The causes of this difference are not fully understood, although
sex hormones may play an important role in glucose tolerance
[8, 9]. On the other hand, there has been no detailed report on
the progression of diabetes in female SDT rats. In the present
study, therefore, we performed glucose tolerance tests and bio-
chemical and histopathological examinations to elucidate the
process of diabetes in female SDT rats at 16 and/or 25 weeks
of age, before the onset of diabetes.
MATERIALS AND METHODS
Animals
Female SDT rats were raised at the Yaotsu Branch of the
TechnicalServiceDept,ofCLEAJapan,Inc.(Gifu,Japan).Fe-
male Sprague-Dawley (SD) rats (Jcl:SD, CLEA Japan, Tokyo,
Japan)matchedforagewereusedascontrolanimals.Alltherats
were maintained in animal facilities under speciﬁc pathogen-
free conditions where the temperature (20–26◦C), humidity
(50–70%), and lighting (07:00–19:00 h) were controlled. The
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animals were allowed free access to a commercial pellet (CE-
2, CLEA Japan, Tokyo) and sterilized tap water from an au-
tomatic water supply system. By 25 weeks of age, the female
SDT rats were checked weekly for glucosuria using URIACE
(TERUMO, Tokyo), and diagnosed as being diabetic if the uri-
nary glucose was 3+ or higher.
Oral Glucose Tolerance Test
At 16 and 25 weeks of age, female SDT and control SD
rats were subjected to an oral glucose tolerance test (OGTT)
after 18 h of fasting. Glucose 2 g/kg body weight was admin-
istered by gavage, and blood samples were collected from a
tail vein without anesthesia at 0 (preoral administration of glu-
cose), 60 and 120 min to measure plasma glucose and insulin.
Plasma glucose was measured by the hexokinase method using
COBAS MIRA Plus (Roche, Tokyo). Plasma insulin was mea-
sured using an enzyme-linked immunosorbent assay (ELISA)
kit (rat insulin kit, Wako, Osaka, Japan). Rats with >185 mg/dl
of plasma glucose at 120 min after the administration of glu-
cose were diagnosed as having impaired glucose tolerance
(IGT).
Clinical Examinations and Biochemical Analysis
At 25 weeks of age, female SDT and control SD rats were
placed in metabolic cages and after an 18-h fast, all the animals
were anesthetized with ether, weighed, and exsanguinated to
death.Bloodsamplesweredrawnfromtheabdominalaortaus-
ing a heparinized syringe. The heparinized blood samples were
centrifuged at 2,000 rpm for 15 min and the plasma was frozen
at –80◦C until analysis. The plasma concentrations of choles-
terol, triglycerides and nonesteriﬁed fatty acids (NEFAs) were
measured enzymatically using COBAS MIRA Plus (Roche).
Immunoreactive leptin in plasma was determined using an
enzyme-linked immunosorbent assay (ELISA) kit (Immuno-
Biological Laboratories Co., Gunma, Japan).
TABLE 1
Plasma glucose and insulin responses in female SDT and control SD rats subjected to an oral glucose tolerance test at
16 and 25 weeks of age
Plasma glucose (mg/dl) Plasma insulin (ng/ml)
Age in No. of
weeks Strain animals 0 min 60 min 120 min 0 min 60 min 120 min
16 SD 6 112.8 ± 5.9 175.5 ± 7.4 161.7 ± 8.6 0.49 ± 0.09 0.62 ± 0.13 0.56 ± 0.1
SDT 6 130.6 ± 3.4* 232.6 ± 13.9† 159.3 ± 8.5 0.62 ± 0.03 1.21 ± 0.16* 0.74 ± 0.1
25 SD 6 124.9 ± 7.2 180.7 ± 8.7 167.9 ± 7.4 1.19 ± 0.24 1.25 ± 0.24 1.21 ± 0.14
SDT 6 145.1 ± 4.3* 312.0 ± 44.6* 253.9 ± 19.2† 1.17 ± 0.13 1.54 ± 0.11 1.64 ± 0.11*
Values are expressed as the mean ±SE+A1.
∗P < 0.05 versus the control SD rat group.
†P < 0.01versus the control SD rat group.
Histopathological Examinations
The pancreas from 25-week-old female SDT rats was ﬁxed
in 10% neutral buffered formalin. The ﬁxed specimens were
embeddedinparafﬁn,sectionedat4µm,andstainedwithhema-
toxylin and eosin (H&E) for histopathological examination.
Statistical Analysis
The data are expressed as the mean±SE . Differences be-
tween the female SDT and age-matched control SD rats were
assessedbyStudent’st-test.Probabilityvaluesof P <0.05were
considered as denoting statistical signiﬁcance.
RESULTS
Glucose Tolerance
The results of OGTT in 16- and 25-week-old SDT and con-
trol SD rats are shown in Table 1. At 16 weeks of age, SDT rats
had signiﬁcantly higher plasma concentrations of glucose than
the control rats, both at 0 and 60 min after the administration of
glucose. At 25 weeks of age, the plasma concentration of glu-
cose at 0, 60, and 120 min after the administration of glucose
was signiﬁcantly increased in the SDT rats indicating IGT. At
60 min after the administration of glucose, the plasma concen-
tration of insulin was signiﬁcantly higher in SDT rats 6 weeks
of age. At 120 min after the administration of glucose, the con-
centration of insulin was also signiﬁcantly higher in SDT rats
25 weeks of age.
Clinical Examinations and Biochemical Analysis
Glucosuria was not detected in SDT rats 25 weeks of age.
The body weight and fasting plasma triglycerides, total choles-
terol, NEFA and leptin concentrations in SDT and control SD
rats are shown in Table 2. The body weight of SDT rats was
signiﬁcantly higher (P < 0.05) than that of control rats. Plasma
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TABLE 2
Body weight and fasting plasma concentrations of
triglycerides, total cholesterol, nonesteriﬁed free fatty acids
and leptin in female SDT and control SD rats
at 25 weeks of age
SDT SD
Parameter (n = 6) (n = 6)
Body weight (g) 367.3 ± 8.1* 329.3 ± 12.7
Triglycerides (mg/dl) 91.5 ± 28.1* 22.7 ± 3.3
Total cholesterol (mg/dl) 83.3 ± 4.1 89.6 ± 4.7
Nonesteriﬁed fatty acids (meq/l) 0.88 ± 0.03† 0.71 ± 0.03
Leptin (pg/ml) 24096 ± 5199 10107 ± 5712
Values are expressed as the mean ±SEM.
∗P < 0.05 versus the control SD rat group.
†P < 0.01versus the control SD rat group.
and 1.2 times higher in SDT rats than in control rats, respec-
tively. On the other hand, the higher concentration of leptin
observed in SDT rats was not signiﬁcantly different from that
in control SD rats and there were no differences between the
two groups regarding their plasma total cholesterol.
Histopathological Findings
ThehistopathologicalfeaturesofthepancreasinfemaleSDT
rats are shown in Figure 1. At 25 weeks of age, hemosiderin
deposition, inﬁltration of lymphocytes and macrophages, and
ﬁbrous tissue proliferation in and around the pancreatic islets
were observed and islets were divided into small lobules by
ﬁbroustissue.Thesehistopathologicchangeswerequalitatively
similar to those observed in male SDT rats [1].
FIGURE 1
Histopathological changes in the pancreas of a female SDT rat
at 25 weeks of age. Inﬂammatory cell inﬁltration and ﬁbrosis
around the pancreatic islets are observed (H&E stain, ×140).
DISCUSSION
ThecharacteristicsofmaleSDTratsareglucoseintolerance
with impaired insulin secretion and lesions in pancreatic islets,
including hemorrhage and inﬂammatory cell inﬁltration, at the
prediabetic stage [1, 10]. In male SDT rats, using the quan-
titative trait locus (QTL) analysis, we identiﬁed three highly
signiﬁcant QTLs (Giadt1, Gisdt2, and Gisdt3) for glucose in-
tolerance on rat chromosomes 1, 2, and X, respectively [11].
In this investigation, we conﬁrmed that glucose intolerance and
pancreatic lesions developed prior to clinical diabetes mellitus
in female SDT rats, the same as in male SDT rats. Therefore,
the glucose-intolerance-related loci involved in male SDT rats
were thought to be also strongly involved in the development
of diabetes in females.
Although there are some differences in the insulin pattern
between males and females [10], the plasma concentrations of
insulin in female SDT rats was higher than that in age-matched
control rats during OGTT. This fact suggested that an insulin-
resistant factor or other factors causing an enhancement of in-
sulin requirements might have been present in the preclinical
stage. Obesity is a well-known factor of insulin resistance [12],
buti nthe present study, as previously reported for males, obe-
sity was not detected. In this study, we also found a signiﬁcant
increase of fasting plasma triglycerides and NEFA at the pre-
diabetic stage. In humans, the increase of VLDL-triglycerides
concentration is closely related to an impairment in the ability
of insulin to suppress NEFAs [13, 14]. In addition, it has been
reported that in 6-week-old OLETF rats, in which insulin resis-
tance had not been manifested, visceral fat weight was already
higher and free fatty acids (FFAs) and VLDL-triglycerides
were elevated, compared with the control rats [15]. In order
to clarify the causal factors of the increased plasma insulin
concentration during OGTT in female SDT rats, further inves-
tigations (e.g., measurement of visceral fat volume) should be
performed.
In the present study, it becomes clear that female SDT rats
suffered from IGT at 25 weeks of age when they had not de-
veloped overt diabetes yet. It seems likely that most female
SDT rats present IGT for a long time and do not develop di-
abetes. According to the diagnostic criteria established by the
World Health Organization in 1998, other categories of hyper-
glycemia included IGT and impaired fasting glycemia (IFG)
[16]. Kadowaki et al. [17] reported that 2% of patients with
IGT proceeded annually to diabetes mellitus in Japan. Further-
more, IGT attracts great attention as an independent risk factor
for coronary heart disease [18,19].
In conclusion, further examination of long-term IGT in fe-
male SDT rats would lead to the clariﬁcation of factors in-
volved in the transition from IGT to diabetes and prevention of
IGT.256 M. SHINOHARA ET AL.
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